229 related articles for article (PubMed ID: 30621723)
1. ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma.
Peng H; Zhang J; Zhang PP; Chen L; Tang LL; Yang XJ; He QM; Wen X; Sun Y; Liu N; Li YQ; Ma J
J Exp Clin Cancer Res; 2019 Jan; 38(1):11. PubMed ID: 30621723
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic mediated zinc finger protein 671 downregulation promotes cell proliferation and tumorigenicity in nasopharyngeal carcinoma by inhibiting cell cycle arrest.
Zhang J; Wen X; Liu N; Li YQ; Tang XR; Wang YQ; He QM; Yang XJ; Zhang PP; Ma J; Sun Y
J Exp Clin Cancer Res; 2017 Oct; 36(1):147. PubMed ID: 29052525
[TBL] [Abstract][Full Text] [Related]
3. Circadian clock gene
Zhao C; Meng X; Li Y; Liu L; He Q; Jiang J; Chen Y; Li X; Li Y; Tang Y; Zhou D; Zhou J; Jin F
Chronobiol Int; 2022 Oct; 39(10):1340-1351. PubMed ID: 35903031
[No Abstract] [Full Text] [Related]
4. Exosomal ERp44 derived from ER-stressed cells strengthens cisplatin resistance of nasopharyngeal carcinoma.
Xia T; Tian H; Zhang K; Zhang S; Chen W; Shi S; You Y
BMC Cancer; 2021 Sep; 21(1):1003. PubMed ID: 34493236
[TBL] [Abstract][Full Text] [Related]
5. NAP1L1 targeting suppresses the proliferation of nasopharyngeal carcinoma.
Liu Y; Li X; Zhang Y; Tang Y; Fang W; Liu X; Liu Z
Biomed Pharmacother; 2021 Nov; 143():112096. PubMed ID: 34563951
[TBL] [Abstract][Full Text] [Related]
6. Quercetin acts as a novel anti-cancer drug to suppress cancer aggressiveness and cisplatin-resistance in nasopharyngeal carcinoma (NPC) through regulating the yes-associated protein/Hippo signaling pathway.
Li T; Li Y
Immunobiology; 2023 Mar; 228(2):152324. PubMed ID: 36608594
[TBL] [Abstract][Full Text] [Related]
7. ZNF582 hypermethylation promotes metastasis of nasopharyngeal carcinoma by regulating the transcription of adhesion molecules Nectin-3 and NRXN3.
Zhao Y; Hong XH; Li K; Li YQ; Li YQ; He SW; Zhang PP; Li JY; Li Q; Liang YL; Chen Y; Ma J; Liu N; Chen YP
Cancer Commun (Lond); 2020 Dec; 40(12):721-737. PubMed ID: 33038291
[TBL] [Abstract][Full Text] [Related]
8. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
[TBL] [Abstract][Full Text] [Related]
9. The circadian clock gene, BMAL1, promotes radiosensitization in nasopharyngeal carcinoma by inhibiting the epithelial-to-mesenchymal transition via the TGF-β1/Smads/Snail1 axis.
Li Y; Zhou Y; Zhao C; Liu L; He Q; Shang K; Xu X; Luo X; Zhou D; Jin F
Oral Oncol; 2024 May; 152():106798. PubMed ID: 38615583
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine synergizes with cisplatin to inhibit nasopharyngeal carcinoma cell proliferation and tumor growth.
He SW; Zhang Y; Chen L; Luo WJ; Li XM; Chen Y; Huang SY; He QM; Yang XJ; Li YQ; Liu N; Zhao Y; Ma J
FASEB J; 2021 Oct; 35(10):e21885. PubMed ID: 34478585
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1.
Hong X; Liu N; Liang Y; He Q; Yang X; Lei Y; Zhang P; Zhao Y; He S; Wang Y; Li J; Li Q; Ma J; Li Y
Mol Cancer; 2020 Feb; 19(1):33. PubMed ID: 32061262
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin suppresses proliferation, migration and invasion of nasopharyngeal carcinoma cells in vitro by repressing the Wnt/β-catenin/Endothelin-1 axis via activating B cell translocation gene 1.
Yin P; Song G; Jiang Z
Cancer Chemother Pharmacol; 2018 May; 81(5):863-872. PubMed ID: 29536130
[TBL] [Abstract][Full Text] [Related]
13. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
14. Exosomal transfer of miR-106a-5p contributes to cisplatin resistance and tumorigenesis in nasopharyngeal carcinoma.
Li J; Hu C; Chao H; Zhang Y; Li Y; Hou J; Huang L
J Cell Mol Med; 2021 Oct; 25(19):9183-9198. PubMed ID: 34469038
[TBL] [Abstract][Full Text] [Related]
15. LncRNA THOR attenuates cisplatin sensitivity of nasopharyngeal carcinoma cells via enhancing cells stemness.
Gao L; Cheng XL; Cao H
Biochimie; 2018 Sep; 152():63-72. PubMed ID: 29959065
[TBL] [Abstract][Full Text] [Related]
16. miR-1278 sensitizes nasopharyngeal carcinoma cells to cisplatin and suppresses autophagy via targeting ATG2B.
Zhao Y; Wang P; Wu Q
Mol Cell Probes; 2020 Oct; 53():101597. PubMed ID: 32407879
[TBL] [Abstract][Full Text] [Related]
17. MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.
Li YQ; Ren XY; He QM; Xu YF; Tang XR; Sun Y; Zeng MS; Kang TB; Liu N; Ma J
Cell Death Dis; 2015 Jan; 6(1):e1618. PubMed ID: 25611392
[TBL] [Abstract][Full Text] [Related]
18. Methylation-associated silencing of miR-9-1 promotes nasopharyngeal carcinoma progression and glycolysis via HK2.
Xu QL; Luo Z; Zhang B; Qin GJ; Zhang RY; Kong XY; Tang HY; Jiang W
Cancer Sci; 2021 Oct; 112(10):4127-4138. PubMed ID: 34382305
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of cisplatin on nasopharyngeal carcinoma cells may be increased via the downregulation of fibroblast growth factor receptor 2.
Pu L; Su L; Kang X
Int J Mol Med; 2019 Jul; 44(1):57-66. PubMed ID: 31115494
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of the tight junction gene CLDN11 by aberrant hypermethylation modulates tubulins polymerization and promotes cell migration in nasopharyngeal carcinoma.
Li HP; Peng CC; Wu CC; Chen CH; Shih MJ; Huang MY; Lai YR; Chen YL; Chen TW; Tang P; Chang YS; Chang KP; Hsu CL
J Exp Clin Cancer Res; 2018 May; 37(1):102. PubMed ID: 29747653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
